Bacterial infections in patients requiring admission for an acute exacerbation of COPD; a 1-year prospective study

Respiratory Medicine

Volumn 97, Issue 7, 2003, Pages 770-777

  Groenewegen, Karin H ^a   Wouters, Emiel F M ^a  

^a MAASTRICHT UNIVERSITY MEDICAL CENTER   (Netherlands)

Author keywords

Acute exacerbations; Bacterial infections; Chronic obstructive; Pulmonary disease

Indexed keywords

AMOXICILLIN; AMOXICILLIN PLUS CLAVULANIC ACID; ANTIBIOTIC AGENT; AZITHROMYCIN; CORTICOSTEROID; DOXYCYCLINE;

ADULT; AGED; ARTICLE; ARTIFICIAL VENTILATION; BACTERIAL INFECTION; BACTERIUM ISOLATION; BLOOD GAS; CHRONIC OBSTRUCTIVE LUNG DISEASE; CLINICAL FEATURE; CONTROLLED STUDY; CORRELATION ANALYSIS; DISEASE EXACERBATION; DISEASE SEVERITY; FEMALE; FORCED EXPIRATORY VOLUME; HAEMOPHILUS INFLUENZAE; HOSPITAL ADMISSION; HOSPITAL PATIENT; HUMAN; INCIDENCE; INTENSIVE CARE UNIT; LENGTH OF STAY; LUNG FUNCTION; LUNG INFECTION; MAJOR CLINICAL STUDY; MALE; POPULATION RESEARCH; PRIORITY JOURNAL; PROSPECTIVE STUDY; PSEUDOMONAS AERUGINOSA; SPUTUM CULTURE; STREPTOCOCCUS PNEUMONIAE;

EID: 0037490130     PISSN: 09546111     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0954-6111(03)00026-X     Document Type: Article

References (34)

1. Rutten-van Molken MPH, Postma MJ, van Genugten MLL, Joore MA, Leidl R, Jager JC. Current and future medical costs of asthma and chronic obstructive pulmonary disease in The Netherlands. Respir Med 1999;93:779-87.
2. Seemungal TAR, Donaldson GC, Paul EA, Bestall JC, Jeffries DJ, Wedzicha JA. Effect of exacerbation on quality of life in patients with chronic obstructive pulmonary disease. Am J Resp Crit Care Med 1998;157:1418-22.
3. Burge PS, Calverley PMA, Jones PW, Spencer S, Anderson JA, Marlen TK. Randomized, double blind, placebo controlled study of fluticasone propionate in patients with moderate to severe chronic obstructive pulmonary disease: the ISOLDE trial. BMJ 2000;320:1297-303.
4. Gompertz S, Bayley DL, Hill SL, Stockley RA. Relationship between airway inflammation and the frequency of exacerbations in patients with smoking related COPD. Thorax 2001;56:36-41.
5. Bhowmik A, Seemungal TAR, Sapsford RJ, Wedzicha JA. Relation of sputum inflammatory markers to symptoms and lung function changes in COPD exacerbations. Thorax 2000;55:114-20.
6. Murphy TF, Sethi S. Bacterial infection in chronic obsructive pulmonary disease. Am Rev Resp Dis 1992;46:1067-83.
7. Hirschmann JV. Do bacteria cause exacerbations of COPD? Chest 2000;118:193-203.
8. Murphy TF, Sethi S, Niederman MD. The role of bacteria in exacerbations of COPD. Chest 2000;118:204-9.
9. Adams SG, Melo J, Luther MS, Anzueto A. Antibiotics are associated with lower relapse rates in outpatients with acute exacerbations of COPD. Chest 2000;117:1345-52.
10. Monso E, Ruiz J, Manterola J, et al. Bacterial infection in chronic obstructive pulmonary disease. A study of stable and exacerbated outpatients using the protected specimen brush. Am J Resp Crit Care Med 1995;152:1316-20.
11. Cabello H, Torres A, Celis R, et al. Bacterial colonization of distal airways in healthy subjects and chronic lung disease: a bronchoscopic study. Eur Resp J 1997;10:1137-44.
12. Eller J, Ede A, Schaberg T, Niederman MS, Mauch H, Lode H. Infective exacerbations of chronic bronchitis. Relation between bacterial etiology and lung function. Chest 1998;113:1542-8.
13. Miravitlles M, Espinosa C, Fernandez-Laso E, Martos JA, Maldonado JA, Gallego M. Relationship between bacterial flora in sputum and functional impairment in patients with acute exacerbations of COPD. Chest 1999;116:40-6.
14. Soler N, Torres A, Ewig S, et al. Bronchial microbial patterns in severe exacerbations of chronic obstructive pulmonary disease (COPD) requiring mechanical ventilation. Am J Resp Crit Care Med 1998;157:1498-505.
15. Connors AF, Dawson NV, Thomas C, et al. Outcomes following acute exacerbation of severe chronic obstructive lung disease. Am J Resp Crit Care Med 1996;154:959-67.
16. American Thoracic Society. Standards for the diagnosis, care of patients with chronic obstructive pulmonary disease. Am Rev Respir Dis 1995;152:S78-83.
17. Global initiative for chronic obstructive pulmonary disease. Global strategy for the diagnosis, management and prevention of chronic obstructive pulmonary disease. NHLBI/WHO Workshop Report.
18. Isenberg HD, Baron EJ, Damato RF, et al. Recommendations for the isolation of bacteria from clinical specimens. In: Balows A, Hausler Jr WJ, Herrmann KL et al., editors. Manual of clinical microbiology. Washington, DC: American Society for Microbiology, 1991. p. 231-7.
19. Pang JA, Cheng A, Chan HS, Poon D, French G. The bacteriology of bronchiectasis in Hong Kong investigated by protected catheter brush and bronchoalveolar lavage. Am Rev Resp Dis 1989;139(1):14-7.
20. Niederman MS, Mantovani R, Schoch P, Papas J, Fein AM. Patterns and routes of tracheobronchial colonization in mechanically ventilated patients. The role of nutritional status in colonization of the lower airway by Pseudomonas species. Chest 1989;95:947-52.
21. Vincent JL. Microbial resistance: lessons from the epic study. Intensive Care Med 2000;26:S3-8.
22. Fagon J-Y, Chastre J, Trouillet J-L, et al. Characterization of distal bronchial microflora during acute exacerbation of chronic bronchitis. Am Rev Resp Dis 1990;142:1004-8.
23. Bresser P, van Alphen L, Habets FJM, et al. Persisting Haemophilus influenzae strains induce lower levels of interleukin-6 and interleukin-8 in H292 lung epithelial, cells than non-persisting strains. Eur Resp J 1997;10: 2319-26.
24. Bresser P, Out T, van Alphen L, Jansen HM, Lutter R. Airway inflammation in nonobstructive and obstructive chronic bronchitis with chronic Haemophilus influenzae airway infection. Am J Resp Crit Care Med 2000;162:852-947.
25. Sethi S, Muscarella K, Evans N, Klingman KL, Grant BJ, Murphy TF. Airway inflammation and etiology of acute exacerbations of chronic bronchitis. Chest 2000;118: 1557-65.
26. Sethi S, Evans N, Wrona C, Murphy TF. Airway inflammation in COPD: effects of clinical status and bacterial infection. A815. ATS 2002.
27. Downey D, Brockbank S, Ennis M, Elborn S. The effect of infective exacerbations on chronic obstructive pulmonary disease on sputum cell counts. A821. ATS 2000.
28. Saint S, Bent S, Vittinghoff E, Grady D. Antibiotics in chronic obstructive pulmonary disease exacerbations: a meta-analysis. JAMA 1995;273:957-60.
29. Bach PB, Brown C, Gelfand SE, et al. Management of acute exacerbations of chronic obstructive pulmonary disease: a summary and appraisal of published evidence. Ann Int Med 2001;134(7):600-20.
30. Bonten MJM, Bergmans DCJJ, Stobberingh EE, et al. Implementation of bronchoscopic techniques in the diagnosis of ventilator-associated pneumonia to reduce antibiotic use. Am J Resp Crit Care Med 1997;156:1820-4.
31. Froon AHM, Bonten MJM, Gaillard CA, et al. Prediction of clinical severity and outcome of ventilator-associated pneumonia. Am J Resp Crit Care Med 1998;158:1026-31.
32. Soler N, Torres A, Celis R, et al. Bronchial microbial patterns in non-severe exacerbations of COPD: a bronchoscopic study. A307. ATS 2000.
33. Blasi F, Legnani D, Lombardo VM, et al. Chlamydia pneumoniae infection in acute exacerbations of COPD. Eur Resp J 1993;6:19-22.
34. Mogulkoc N, Karakurt S, Isalska B, et al. Acute purulent exacerbation of chronic obstructive pulmonary disease and Chlamydia pneumoniae infection. Am J Resp Crit Care Med 1999;160:349-53.